Literature DB >> 11600750

Revisiting Sjögren's syndrome in the new millennium: perspectives on assessment and outcome measures. Report of a workshop held on 23 March 2000 at Oxford, UK.

S J Bowman1, S Pillemer, R Jonsson, K Asmussen, C Vitali, R Manthorpe, N Sutcliffe.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11600750     DOI： 10.1093/rheumatology/40.10.1180

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  10 in total

1.  EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome.

Authors:  Raphaèle Seror; Philippe Ravaud; Simon J Bowman; Gabriel Baron; Athanasios Tzioufas; Elke Theander; Jacques-Eric Gottenberg; Hendrika Bootsma; Xavier Mariette; Claudio Vitali
Journal:  Ann Rheum Dis       Date:  2009-06-28       Impact factor: 19.103

Review 2.  Management of primary Sjögren's syndrome: recent developments and new classification criteria.

Authors:  Nicoletta Del Papa; Claudio Vitali
Journal:  Ther Adv Musculoskelet Dis       Date:  2018-01-01       Impact factor: 5.346

3.  [Sjögren's syndrome. Current aspects from a rheumatological point of view].

Authors:  C Tomiak; T Dörner
Journal:  Z Rheumatol       Date:  2006-10       Impact factor: 1.372

4.  Lamivudine is not effective in primary Sjögren's syndrome.

Authors:  B Gescuk; A J Wu; J P Whitcher; T E Daniels; S Lund; K Fye; J C Davis
Journal:  Ann Rheum Dis       Date:  2005-02-11       Impact factor: 19.103

5.  Patient burden of Sjögren's: a comprehensive literature review revealing the range and heterogeneity of measures used in assessments of severity.

Authors:  Katherine M Hammitt; April N Naegeli; Remon W M van den Broek; Julie A Birt
Journal:  RMD Open       Date:  2017-09-17

Review 6.  A review of scoring systems for ocular involvement in chronic cutaneous bullous diseases.

Authors:  Brendon W H Lee; Jeremy C K Tan; Melissa Radjenovic; Minas T Coroneo; Dedee F Murrell
Journal:  Orphanet J Rare Dis       Date:  2018-05-22       Impact factor: 4.123

7.  The reliability and validity of the European League Against Rheumatism Sjögren Syndrome Patient Reported Index in patients with primary Sjögren syndrome: A Turkish version study.

Authors:  Elif Gür Kabul; Aylin Keskin; Pervin Demir; Bilge Başakcı Çalık; Veli Çobankara
Journal:  Arch Rheumatol       Date:  2020-10-05       Impact factor: 1.472

Review 8.  Outcome selection for tissue-agnostic drug trials for immune-mediated inflammatory diseases: a systematic review of core outcome sets and regulatory guidance.

Authors:  Olalekan Lee Aiyegbusi; Lavinia Ferrante di Ruffano; Ameeta Retzer; Philip N Newsome; Christopher D Buckley; Melanie J Calvert
Journal:  Trials       Date:  2022-01-15       Impact factor: 2.279

9.  Mycophenolate sodium treatment in patients with primary Sjögren syndrome: a pilot trial.

Authors:  Peter Willeke; Bernhard Schlüter; Heidemarie Becker; Heiko Schotte; Wolfram Domschke; Markus Gaubitz
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

10.  Beyond the Glands: An in-Depth Perspective of Neurological Manifestations in Sjögren's Syndrome.

Authors:  Alexandria Voigt; Sukesh Sukumaran; Cuong Q Nguyen
Journal:  Rheumatology (Sunnyvale)       Date:  2014
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.